Dianthus Therapeutics, Inc. /DE/ (DNTH) Total liabilities 2017–2025
Dianthus Therapeutics, Inc. /DE/ (DNTH) total liabilities at each fiscal year-end, per SEC filings.
$37.5MFY2025 · since FY2017: $4.1M → $37.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $37.5M | +74.3% |
| FY2024 | $21.5M | +104.4% |
| FY2023 | $10.5M | +11.4% |
| FY2022 | $9.5M | +76.6% |
| FY2021 | $5.4M | — |
| FY2019 | $20.3M | +74.2% |
| FY2018 | $11.7M | +181.6% |
| FY2017 | $4.1M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More DNTH financial trends
DNTH RevenueDNTH Net incomeDNTH Net marginDNTH Gross profitDNTH Gross marginDNTH Operating incomeDNTH Operating marginDNTH Operating cash flowDNTH Free cash flowDNTH Capital expendituresDNTH Return on equityDNTH Stock buybacksDNTH Dividends paidDNTH Total assetsDNTH Shareholders’ equityDNTH overview →